Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein2002· article· en· Neuron· Medicinefundno affno abstract1,259citations
Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and α-Synuclein2006· article· en· Journal of Biological Chemistry· Medicinefundno aff1,125citations
Sensitivity of secondary structure propensities to sequence differences between α‐ and γ‐synuclein: Implications for fibrillation2006· article· en· Protein Science· Medicineafffund742citations
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction2023· review· en· Cell Death and Disease· Medicinefundno aff739citations
Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease2013· article· en· Movement Disorders· Medicineafffund662citations
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study2011· article· en· The Lancet Neurology· Medicineaffno abstract629citations
Alpha‐synuclein <scp>RT</scp>‐Qu<scp>IC</scp> in the <scp>CSF</scp> of patients with alpha‐synucleinopathies2016· article· en· Annals of Clinical and Translational Neurology· Medicinefundno aff613citations
α-Synuclein Membrane Interactions and Lipid Specificity2000· article· en· Journal of Biological Chemistry· Medicineafffund608citations
REM sleep behaviour disorder2018· review· en· Nature Reviews Disease Primers· Neuroscienceaffno abstract487citations
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease2018· article· en· Science· Medicineaff465citations
Induction of α-Synuclein Aggregation by Intracellular Nitrative Insult2001· article· en· Journal of Neuroscience· Medicinefundno aff442citations
Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?2016· review· en· Journal of Parkinson s Disease· Medicineafffund425citations
Alpha-synuclein oligomers: a new hope2017· review· en· Acta Neuropathologica· Medicineaff356citations
Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy2009· article· en· PLoS ONE· Medicineafffund347citations
C-terminal calcium binding of α-synuclein modulates synaptic vesicle interaction2018· article· en· Nature Communications· Medicineaff335citations
Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study2021· article· en· The Lancet Neurology· Medicinefundno affno abstract332citations
α-Synuclein strains target distinct brain regions and cell types2019· article· en· Nature Neuroscience· Biochemistry, Genetics and Molecular Biologyaffno abstract329citations
CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy2011· article· en· Proceedings of the National Academy of Sciences· Medicineaff317citations
Acid β‐glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α‐synuclein processing2011· article· en· Annals of Neurology· Medicineaff305citations
α‐Synuclein oligomers and clinical implications for Parkinson disease2012· review· en· Annals of Neurology· Medicineafffund291citations
Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo2009· article· en· Molecular Brain· Medicineafffund281citations
The prion hypothesis in Parkinson's disease: Braak to the future2013· review· en· Acta Neuropathologica Communications· Biochemistry, Genetics and Molecular Biologyaff272citations
GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synuclein2008· article· en· Proceedings of the National Academy of Sciences· Medicineaff268citations
Interface between tauopathies and synucleinopathies: A tale of two proteins2006· review· en· Annals of Neurology· Medicineaff264citations